FDA Inspection
Oxford Pharmaceuticals, LLCOxford Pharmaceuticals, LLC – FDA Inspection, Nov 3, 2023
Record Details
This FDA Inspection record concerns Oxford Pharmaceuticals, LLC, with an inspection on November 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0e32951c-75a0-4d53-b01e-ec21522685b5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1221787
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oxford Pharmaceuticals, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 2, 2026 | Not classified | New Orleans District Office | Drug Quality Assurance |
| June 8, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Oxford Pharmaceuticals, LLC
- FDA Inspection 1334078 - 2026-09-02
- FDA Inspection 1174389 - 2022-06-08
- FDA Inspection 1092451 - 2019-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.